Physician profile
Donna Lan Pham
NPI 1598940975
$716.90
in general payments reported to CMS, 2019-2025
11 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $134 · 2022: $325 · 2023: $128 · 2024: $15.27 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $257.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $355.27 | 2021-2023 | Resonate El Icd Vr |
| Polynovo North America LLC | $114.48 | 2025 | Novosorb Btm |
| Amgen INC. | $68.44 | 2021-2023 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.58 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $35.27 | 2022-2023 | Fasenra |
| E.R. Squibb & Sons, L.L.C. | $24.55 | 2023 | Eliquis |
| Novartis Pharmaceuticals Corporation | $21.30 | 2022 | |
| Biotronik INC. | $15.70 | 2022 | |
| Pfizer INC. | $15.28 | 2021 | |
| Irhythm Technologies, INC. | $15.27 | 2024 | Zio Monitor, Zio Xt Patch |
| Medtronic, INC. | $14.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.